News & Insights

Gunderson Dettmer advised Theravance Biopharma, Inc., a diversified biopharmaceutical company focused on the discovery, development and commercialization of organ-selective medicines, in a $100.5M follow-on public offering.

Gunderson Dettmer client ChargePoint, a leading electric vehicle (EV) charging network, announced the signing of a definitive business combination agreement with Switchback Energy Acquisition Corporation, a publicly-traded special purpose acquisition company (SPAC).

Theravance announces its follow-on public offering of 5,500,000 shares at a price to the public of $27.00 per share for gross proceeds of approximately $148.5 million.

19 Gunderson Dettmer attorneys are recognized in the 2025 edition of Lawdragon's 500 Leading Dealmakers in America list, highlighting their expertise in various practice areas

19 Gunderson Dettmer attorneys were recognized in the 2024 edition of Lawdragon’s 500 Leading Dealmakers in America. 

Gunderson Dettmer was ranked Tier 1 by The Legal 500 in U.S. 2022 for the firm’s work in venture capital and emerging companies, which also recognized seven (7) partners from across our U.S. offices.